Thrombomodulin Alfa Completed Phase 3 Trials for Coagulation Disorders / Severe Sepsis Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01598831Phase 3 Safety and Efficacy Study of ART-123 in Subjects With Severe Sepsis and Coagulopathy